Rising Tobacco Prices and Regulations in Lithuania

Dec.13.2022
Rising Tobacco Prices and Regulations in Lithuania
Lithuania's tobacco prices set to rise in 2023 due to increases in consumer taxes and tighter restrictions on tobacco products.

In 2023, tobacco products prices in Lithuania are expected to increase.


In 2021, an amendment to the Consumption Tax Law was passed, which is expected to result in an increase in the consumption tax rate between 2022 and 2024.


As explained to 15min by the Ministry of Finance, the average price of a pack of cigarettes (20 cigarettes) may increase by approximately €0.18 due to tax factors in the coming years. The average prices for 20g of small cigars or cigars may increase by around €0.31, while 20g of smoking tobacco may increase by about €0.18. Furthermore, the tobacco market in Lithuania will face greater restrictions in the near future. As announced, on November 24th, Seimas will legalize shops or departments specifically for smokers, including e-cigarettes. These establishments will begin operating in 2025, and regular shops will no longer be able to openly display smoking accessories.


On Thursday, members of Congress passed the revised Tobacco, Tobacco-Related Products and Associated Products Control Law of 2019. Of the 74 participating members, 44 voted in favor, 13 opposed, and 17 abstained. The amendment states that tobacco shops can only sell tobacco products and related goods, but must refrain from displaying them in external showcases. Other stores will be prohibited from publicly showcasing such products, permitting only the display of the smoker's name and the packaging or the package's price.


2FIRSTS will continue to track and report on this issue. Further updates will be available on the "2FIRSTSAPP". Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Frank Vandenbroucke described the tobacco industry as a “criminal” sector with “no future” during an appearance on VRT’s current affairs program Ter Zake. His comments came after Belgium’s Constitutional Court ruled that a government ban on cigarette and vape sales in supermarkets was discriminatory because it allowed small shops to sell tobacco products while prohibiting larger retailers from doing so.
May.07 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
According to The Wall Street Journal, people familiar with the matter said President Trump has signed off on a plan to fire FDA Commissioner Marty Makary, though the plan is not yet final and could change. The report said Makary’s tenure has included clashes over vaping, abortion and drug policy, and that some senior administration officials view him as struggling to manage the agency.
May.09 by 2FIRSTS.ai
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
mperial Brands has launched blu MAX 6000 in the UK, positioning the product as a higher-puff vape kit with longer-lasting use and replaceable pod+refill options. The device uses a 2ml+10ml click-on box format, with starter kits priced at £10.99 (approximately $14) and replacement pod+refill packs priced at £7.99 (approximately $10).
Market
May.19